What is the best first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone?

Zhao H, Cai H, Wang C, et al.

Am J Hematol · 2019

Key Findings

  • Compared ASCT (n=165), MDex (n=79), LDex (n=103) as first-line therapy
  • ASCT achieved highest hematologic CR (49.7%)
  • Neurological remission similar across groups (~93%)
  • 3-year PFS 80.5%, 3-year OS 90.8% overall

Referenced in (1 disease)

Validation history

Full log →
  1. passsource metadataJun 1, 2026, 04:40 PMby pubmed-api

    Stored DOI was incorrect; corrected to the PubMed-registered DOI (verified to resolve to this article).

    tools: pubmed.esummary, crossref.works

ID: pmid-30700844DOI: 10.1038/s41375-019-0391-2PMID: 30700844